Pharmaceuticals

Glycopeptide Antibiotics Market Size and Growth Forecast for Businesses 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Glycopeptide Antibiotics Market Size During 2025–2029?

The glycopeptide antibiotics market size has demonstrated robust growth in recent years. It is forecast to grow from $3.54 billion in 2024 to $3.78 billion in 2025, at a compound annual growth rate (CAGR) of 7.0%. The expansion observed in the historic period can be attributed to increasing antibiotic resistance, a rising incidence of infectious diseases, government initiatives, increasing healthcare expenditure, and the globalization of infectious diseases.

The glycopeptide antibiotics market size is projected to experience robust expansion in the coming years. Its value is anticipated to reach $5.38 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period stems from factors such as emerging infectious diseases, a rising elderly population, persistent issues with antibiotic resistance, investments and innovations in R&D, and the broadening of healthcare infrastructure. Key trends for the upcoming period encompass escalating antibiotic resistance, progress in research and development, global health crises boosting demand, partnerships for antibiotic stewardship, and market penetration into developing economies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9444&type=smp

Which Drivers Are Shaping The Glycopeptide Antibiotics Industry’s Market Share?

The increasing prevalence of cancer and infectious diseases is anticipated to fuel the expansion of the glycopeptide antibiotics market in the future. Cancer involves the uncontrolled multiplication and spread of certain body cells, while infectious diseases stem from agents like bacteria, viruses, fungi, or parasites. Glycopeptide antibiotics are effective against various infectious conditions caused by resistant bacteria such as methicillin-resistant staphylococcus aureus, streptococcus, or enterococcus. Furthermore, in individuals with cancer, these antibiotics enhance the anti-tumor effects of radiotherapy by targeting both localized and distant cancer cells. As an illustration, the American Cancer Society reported that in 2022, the US recorded 1.9 million new cancer cases and 609,360 cancer deaths, equating to 1,670 daily fatalities. Consequently, the growing incidence of cancer and infectious diseases will stimulate the glycopeptide antibiotics market’s development.

What Are The Emerging Segments Gaining Attention In The Glycopeptide Antibiotics Market?

The glycopeptide antibiotics market covered in this report is segmented –

1) By Drug: Vancomycin, Dalbavancin, Oritavancin, Other Drugs

2) By Route of Administration: Oral, Parenteral, Other Routes

3) By Indication: Skin And Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Other Indications

4) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Vancomycin: Vancomycin Injection, Vancomycin Oral Solution, Vancomycin Capsules, Vancomycin Powder for Solution

2) By Dalbavancin: Dalbavancin IV (Intravenous) Formulation, Dalbavancin Powder for Injection

3) By Oritavancin: Oritavancin IV (Intravenous) Formulation,Oritavancin Powder for Injection

4) By Other Drugs: Teicoplanin, Linezolid, Daptomycin, Other Glycopeptide and Lipoglycopeptide Antibiotics

What Trends Are Expected To Drive The Glycopeptide Antibiotics Market?

Product innovation is a key trend gaining popularity in the glycopeptide antibiotics market. Major companies operating in the glycopeptide antibiotics market are focused on developing innovative products to strengthen their position in the market. For instance, in October 2022, Leiden University, a Netherlands-based research university, discovered new variants of the antibiotic vancomycin. A group of molecules was attached to the structure of an existing vancomycin molecule to create the new variant antibiotic vancomycin. The new variant of vancomycin is up to a thousand times more active against gram-positive bacteria than the original vancomycin and has lower nephrotoxicity when compared to commercially utilized polymyxin antibiotics. This was created to solve the problem since vancomycin can only be effective against gram-positive strains and it cannot pass through the outer membrane (OM) of gram-negative bacteria.

Who Are The Primary Competitors In The Global Glycopeptide Antibiotics Market?

Major companies operating in the glycopeptide antibiotics market include ANI Pharmaceuticals Inc., Fresenius SE & Co. KGaA, Pfizer Inc., Novartis AG, Hikma Pharmaceuticals Plc., Aurobindo Pharma Limited, Abbvie Inc., Cumberland Pharmaceuticals Inc., Janssen Global, Bristol-Myers Squibb Company, Shenwei Pharmaceutical Hainan Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd., Alvogen, Bayer AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi SA, GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim GmbH, Cipla Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Glycopeptide Antibiotics Market?

North America was the largest region in the glycopeptide antibiotics market in 2024. The regions covered in the glycopeptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Glycopeptide Antibiotics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9444&type=smp

Browse Through More Reports Similar to the Global Glycopeptide Antibiotics Market 2025, By The Business Research Company

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Nutritional Feed Additives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Pharmacies And Drug Stores Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795